-
1دورية أكاديمية
المؤلفون: Scheen, André
المصدر: Médecine des Maladies Métaboliques, 15 (8), 734 - 743 (2021)
مصطلحات موضوعية: Anorectic drugs, Gastrointestinal peptides, Glucagon-like peptide-1, Obesity, Pharmacotherapy, Safety, antiobesity agent, gastrointestinal hormone, glucagon like peptide 1 receptor agonist, glucagon receptor agonist, hormone receptor stimulating agent, liraglutide, semaglutide, body weight loss, chronic disease, drug safety, drug tolerance, human, hypertension, non insulin dependent diabetes mellitus, obesity, Short Survey, Human health sciences, Pharmacy, pharmacology & toxicology, Sciences de la santé humaine, Pharmacie, pharmacologie & toxicologie
العلاقة: urn:issn:1957-2557; urn:issn:2214-8477
الوصول الحر: https://orbi.uliege.be/handle/2268/300339Test
-
2دورية أكاديمية
المؤلفون: Scheen, André
المصدر: Médecine des Maladies Métaboliques, 16 (4), 336 - 342 (2022)
مصطلحات موضوعية: Amputation, DPP-4 inhibitor, Gliflozin, GLP-1, Peripheral arteriopathy, Type 2 diabetes, dipeptidyl peptidase IV inhibitor, glucagon like peptide 1 receptor agonist, placebo, sodium glucose cotransporter 2 inhibitor, Article, drug safety, fear, human, leg amputation, non insulin dependent diabetes mellitus, pharmacovigilance, randomized controlled trial (topic), risk, risk reduction, Human health sciences, Endocrinology, metabolism & nutrition, Pharmacy, pharmacology & toxicology, Sciences de la santé humaine, Endocrinologie, métabolisme & nutrition, Pharmacie, pharmacologie & toxicologie
العلاقة: urn:issn:1957-2557; urn:issn:2214-8477
الوصول الحر: https://orbi.uliege.be/handle/2268/300354Test
-
3دورية أكاديمية
المؤلفون: Scheen, André
المصدر: Médecine des Maladies Métaboliques, 16 (3), 264 - 270 (2022)
مصطلحات موضوعية: DPP-4 inhibitor, Elderly, Gliflozin, Gliptin, SGLT2 inhibitor, Type 2 diabetes, dipeptidyl peptidase IV inhibitor, glucose, sodium glucose cotransporter 2 inhibitor, Article, cardiovascular risk, chronic kidney failure, diabetes control, drug choice, drug safety, drug tolerability, glycemic control, human, major adverse cardiac event, non insulin dependent diabetes mellitus, risk reduction, Human health sciences, Endocrinology, metabolism & nutrition, Pharmacy, pharmacology & toxicology, Sciences de la santé humaine, Endocrinologie, métabolisme & nutrition, Pharmacie, pharmacologie & toxicologie
العلاقة: urn:issn:1957-2557; urn:issn:2214-8477
الوصول الحر: https://orbi.uliege.be/handle/2268/300347Test